Testing Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
University of Michigan
Study ID
NCT07191327
Status
Recruiting

Conditions

  • Posterior Cortical Atrophy

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • HD-tDCS sessions — DEVICE
    This project translates decades of observational neuroimaging research into a biologically plausible stimulation target (i.e., DAN) and uses functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) to plan personalized brain stimulation and to ensure target engagement. When available; those not MRI compatible will receive a standard montage with per channel amplitudes of up to 5 milliamperes (mA) or a montage derived from other imaging methods. Participants will receive 4 days of HD-tDCS sessions in person. During these sessions participants will have electrodes placed on different areas of the head and held in place with headgear. Participants may also have memory and thinking tests during and after the sessions as well as questionnaires about the experience. Additionally, on the fourth day participants may have repeat immersive virtual reality (iVR) as well as other study activities.
  • Sham HD-tDCS sessions — DEVICE
    Participants will receive 4 days of sham HD-tDCS sessions in person. During these sessions participants will have electrodes placed on different areas of the head and held in place with headgear. Participants may also have memory and thinking tests during and after the sessions as well as questionnaires about the experience. Additionally, on the fourth day participants may have repeat immersive virtual reality (iVR) as well as other study activities.
  • HD-tDCS sessions - Open-label (after randomized treatment) — DEVICE
    Optional 26 weeks of additional HD-tDCS sessions. Participants can complete up to 5 days per week, but most people will complete about 3 days per week. The study team may also collect audio recordings of these sessions. Participants can complete this in person or at-home via using a secure, HIPAA-compliant videoconferencing with the supervision of a research staff member. Participant's that decide to complete the additional sessions at home, a research staff member will train a study partner during the first 4 HD-tDCS sessions in the office. This option may not be available or appropriate for all participants and the study team member will discuss this with participant's and study partners.

Study Details

This study is being completed to learn if high-definition transcranial direct current stimulation (HD-tDCS) has an effect on visual and thinking abilities in persons with posterior cortical atrophy (PCA). Participants will be randomized to receive real or sham HD-tDCS (8 sessions over 4 days). Following the randomized treatment, participants will have optional open-label phase with real HD-tDCS up to 26 weeks and other possible testing.

Key Dates

Start date
Jan 28, 2026
Status verified
Mar 2026
Primary completion
Sep 30, 2029
Completion
Sep 30, 2029

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Real stimulation - Randomized
    Four consecutive days (2 sessions for 20 minutes each day for a total of 8 sessions) of this blinded stimulation.
  • Sham Comparator: Sham stimulation - Randomized
    Four consecutive days (2 sessions for 20 minutes each day for a total of 8 sessions) of this blinded stimulation.
  • Experimental: Real stimulation - post randomized treatment
    Participants that agree to this will have up to 26 weeks of additional HD-tDCS sessions at home or in-person.

Primary Outcome Measure

Change in network connectivity measured via fMRI [ Time Frame: Baseline and Day 5 (after 4 days of HD-tDCS) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MichiganAnn ArborMichigan48109
Stephen Schlaefflin, BS
734-936-7360
Eileen Robinson, RN-BC
734-763-1356
Benjamin Hampstead, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Ann Arbor, MI